IXT-m200

DRUG4 trials

Sponsors

InterveXion Therapeutics, LLC

Conditions

HealthyMethamphetamine AbuseMethamphetamine Intoxication (Disorder)Methamphetamine-dependence

Phase 1

Study of Antibody for Methamphetamine Outpatient Therapy

CompletedNCT03336866

InterveXion Therapeutics, LLCMethamphetamine Abuse, Methamphetamine-dependence

Start: 2018-05-03End: 2021-03-09Updated: 2022-03-10

Safety, Tolerability, and Pharmacokinetics of IXT-m200

CompletedNCT05027451

InterveXion Therapeutics, LLCHealthy

Start: 2021-10-25End: 2022-03-18Updated: 2023-06-01

Phase 2

Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose

TerminatedNCT04715230

InterveXion Therapeutics, LLCMethamphetamine Intoxication (Disorder)

Start: 2021-06-30End: 2022-11-14Updated: 2023-11-18

Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200

TerminatedNCT05034874

InterveXion Therapeutics, LLCMethamphetamine Abuse, Methamphetamine-dependence

Start: 2022-06-09End: 2023-11-07Updated: 2024-10-04